Cell & Gene Therapy

The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm
ways to advance orphan drug development and improve access to life-saving therapies.

Advance your innovative biologics pipeline and elevate your engineering, targets and machine learning strategies – accelerating your path to the clinic and beyond.

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies — from discovery to market, with an emphasis on the European region. Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development. Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

The TIDES USA program features concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. Your registration provides access to the presentations across all 4 tracks, allowing you to create your own customized agenda. Each year, TIDES’ scientific agenda includes 150+ of the industry’s top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products. 

Join us for this two day in person event for industry leading updates on a series of topics around temperature-controlled logistics. This will include how to avoid excursions, using data to monitor temperatures, shipping products at deep frozen temperatures and how your peers are coping with new Brexit regulations affecting the supply chain in and out of the 

With our core focus on cell and gene therapy translation, the ISCT Annual Meeting takes an integrative approach across ALL stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access.  Topics are curated to addresses the biggest bottlenecks in cell and gene therapy development.

Engage in scientific discussions on the latest tools and technologies for accelerated NK-based cellular immunotherapy development. Benefit from exclusive insights from global influencers in NK based cell therapy, addressing strategies for safety, quality control and off-target activity assessment, with the goal to fast track to clinic.

A thorough 2 day event addressing emerging strategies for the drug development of Neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases. This in-depth event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing.

A two-day event with dedicated streams on the latest tools and technologies for advanced understanding of cell-based products, including optimised cell line development, strategies to overcome bottlenecks and improved efficacy and safety of cell and gene therapies to ensure clinical and commercial product success.

Explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development. Gain insights to reduce attrition rates and optimise development programmes through eff ective assay development. Learn about the latest multiplexed tools impacting biomarker research and validation, from multi-omic cytometry through to mass spectrometry & immunoassays.